Manufactured by:ProteoGenix
Save 20%RUO

M-MLV

M-MLV from ProteoGenix; catalogue ARO-P12782; research use only.

SKU:
ABM143220-1
Manufacturer SKU
ARO-P12782
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Moloney Murine Leukemia Virus (M-MLV): A Versatile Tool for Recombinant Protein Production and Antigen Expression

Moloney Murine Leukemia Virus (M-MLV) is a retrovirus that has been extensively studied and utilized in molecular biology for its ability to efficiently produce recombinant proteins and express antigens. It was first isolated in 1961 from a mouse with leukemia, and since then, it has become an invaluable tool for researchers in various fields.

Structure of M-MLV

M-MLV belongs to the Retroviridae family and has a simple, yet elegant structure. It is an enveloped virus with a spherical shape, approximately 100 nm in diameter. The viral envelope is derived from the host cell membrane and contains two major glycoproteins, Env and Gag. The viral core is composed of two copies of the viral RNA genome, which is approximately 8.3 kilobases in length, and three viral enzymes: reverse transcriptase, integrase, and protease.

The genome of M-MLV is organized into three main regions: the gag, pol, and env genes. The gag gene encodes for the structural proteins, including the matrix, capsid, and nucleocapsid proteins. The pol gene encodes for the viral enzymes, while the env gene encodes for the envelope glycoproteins. These three regions are flanked by long terminal repeats (LTRs), which are responsible for the viral integration into the host genome.

Activity of M-MLV

The life cycle of M-MLV starts with the attachment of the viral envelope to the host cell surface, followed by fusion and entry of the viral core into the cytoplasm. Once inside the cell, the viral RNA is reverse transcribed into double-stranded DNA by the reverse transcriptase enzyme. The viral DNA then enters the nucleus and integrates into the host genome with the help of the integrase enzyme. The integrated viral DNA, known as a provirus, can remain dormant or be transcribed into viral RNA, which is then translated into viral proteins. The viral proteins are then assembled into new viral particles, which are released from the cell to infect other cells.

The reverse transcriptase enzyme of M-MLV is highly efficient and has a low error rate, making it a valuable tool for reverse transcription and cDNA synthesis in molecular biology experiments. The integrase enzyme is also highly active and has been used in gene therapy studies for its ability to integrate therapeutic genes into the host genome. In addition, the envelope glycoproteins of M-MLV have been extensively studied for their role in viral entry and fusion, providing valuable insights into the mechanisms of viral infection.

Application of M-MLV in Recombinant Protein Production

M-MLV has been widely used as a vector for the production of recombinant proteins in both prokaryotic and eukaryotic systems. The viral genome can be modified to include a gene of interest, which is then expressed in the host cell upon viral infection. This allows for the efficient production of large quantities of recombinant proteins, making M-MLV a popular choice for protein expression in research and industrial settings.

The viral envelope of M-MLV also allows for the production of pseudotyped viruses, which can infect a wide range of cell types. This has been particularly useful for the production of recombinant proteins that are difficult to express in traditional systems. The pseudotyped viruses can also be used for targeted gene delivery, making M-MLV a promising tool for gene therapy applications.

Expression of Antigens with M-MLV

M-MLV has been extensively used for the expression of antigens in vaccine development and diagnostic assays. The viral envelope glycoproteins can be engineered to display specific antigens on their surface, allowing for the production of virus-like particles

ProteoGenix catalogue number ARO-P12782. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 75.85 kDa; Fragment: M-MLV is cloned from MoMLV and expressed in E.coli.; Buffer: 0.01M PBS, pH 7.4..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
0
Host species
E. coli
Source organism
MoMLV
Molecular weight
75.85 kDa
Form / buffer
Liquid
Sequence fragment
M-MLV is cloned from MoMLV and expressed in E.coli.
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P12782
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£225.00£180.00